{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:37:09Z","timestamp":1792060629414,"version":"4.4.0"},"reference-count":30,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> To update the 1999 American Society of Clinical Oncology (ASCO) guideline on breast cancer follow-up and management in the adjuvant setting. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> An ASCO Expert Panel reviewed pertinent information from the literature through March 2006. More weight was given to studies that tested a hypothesis directly relating testing to one of the primary outcomes in a randomized design. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> The evidence supports regular history, physical examination, and mammography as the cornerstone of appropriate breast cancer follow-up. All patients should have a careful history and physical examination performed by a physician experienced in the surveillance of cancer patients and in breast examination. Examinations should be performed every 3 to 6 months for the first 3 years, every 6 to 12 months for years 4 and 5, and annually thereafter. For those who have undergone breast-conserving surgery, a post-treatment mammogram should be obtained 1 year after the initial mammogram and at least 6 months after completion of radiation therapy. Thereafter, unless otherwise indicated, a yearly mammographic evaluation should be performed. Patients at high risk for familial breast cancer syndromes should be referred for genetic counseling. The use of CBCs, chemistry panels, bone scans, chest radiographs, liver ultrasounds, computed tomography scans, [<jats:sup>18<\/jats:sup>F]fluorodeoxyglucose\u2013positron emission tomography scanning, magnetic resonance imaging, or tumor markers (carcinoembryonic antigen, CA 15-3, and CA 27.29) is not recommended for routine breast cancer follow-up in an otherwise asymptomatic patient with no specific findings on clinical examination. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Careful history taking, physical examination, and regular mammography are recommended for appropriate detection of breast cancer recurrence. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2006.08.8575","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T02:57:42Z","timestamp":1160535462000},"page":"5091-5097","source":"Crossref","is-referenced-by-count":419,"title":["American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting"],"prefix":"10.1200","volume":"24","author":[{"given":"James L.","family":"Khatcheressian","sequence":"first","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Wolff","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Grunfeld","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyman B.","family":"Muss","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Vogel","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Halberg","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Somerfield","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Davidson","sequence":"additional","affiliation":[{"name":"From the Virginia Commonwealth University\/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.671"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.8.1718"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7058.665"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.11.2345"},{"key":"R5","unstructured":"Rojas MP, Telaro E, Russo A, et al: Follow-up strategies for women treated for early breast cancer.  Oxford, United Kingdom, Cochrane Library, CD001768, 1, 2005"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510440047031"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7075.174"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510440053032"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.045062"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00011"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.178"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.22.14_suppl.4010"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.19.1445"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1054\/brst.2001.0404"},{"key":"R15","unstructured":"Grunfeld E, Fitzpatrick R, Mant D, et al: Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: Results from a randomized controlled trial. Br J Gen Pract 49:705,1999-710,"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6996.54"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690197"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.2235"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"R20","unstructured":"Institute of Medicine and National Research Council, Committee on Cancer Survivorship: Improving Care and Quality of Life , National Cancer Policy Board. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, National Academies Press, 2005"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1586"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303645"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.620"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.176.6.1761433"},{"key":"R25","unstructured":"Hurria A, Leung D, Trainor K, et al: Screening chest imaging studies are not effective in the follow-up of breast cancer patients. J Oncol Manag 12:13,2003-15,"},{"key":"R26","unstructured":"Vranjesevic D, Filmont JE, Meta J, et al: Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med 43:325,2002-329,"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Kamel EM, Wyss MT, Fehr MK, et al: [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer. J Cancer Res Clin Oncol 129:147,2003-153,","DOI":"10.1007\/s00432-003-0424-z"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-3291-7"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.4960"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66481-1"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.08.8575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:24:39Z","timestamp":1653513879000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.08.8575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":30,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2006,11,1]]}},"alternative-id":["10.1200\/JCO.2006.08.8575"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.08.8575","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}